FDA APPROVES NEW 6-WEEK DOSING FOR KEYTRUDA FOR ALL APPROVED ADULT INDICATIONS

Late Stage Cancer

May 1, 2020 by Fightec.org

FDA Approves New 6-Week Dosing for Keytruda for All Approved Adult Indications

https://www.pharmalive.com/fda-approves-new-6-week-dosing-for-keytruda-for-all-approved-adult-indications/